ABSTRACT We evaluated the relationship between baseline factors defined at 4.6 ± 2.1 hr after onset of acute myocardial infarction and 1 year survival in 245 patients entered in the Western Washington Intracoronary Streptokinase Trial. Univariate statistics identified a significant relationship between 10 of these factors and survival. Multivariate analysis identified three factors as being most closely related to survival: (1) left ventricular ejection fraction (LVEF) (p < .0001), (2) treatment with streptokinase (p = .03), and (3) location of infarction (p = .04). Mathematic models based on this analysis and applied to our patients identified high-and low-risk subgroups for 1 year mortality. Patients receiving standard, not interventional, therapy with anterior infarction and an LVEF of 50% or less and those with inferior infarction and an LVEF of 39% or less comprised the high-risk group. For patients receiving standard therapy, 1 year mortality was 41% in the high-risk group and 4% in the lowrisk group. The models illustrated the magnitude of benefit of streptokinase treatment and achievement of complete reperfusion for those at low and high risk. We conclude that LVEF determined in the first hours of acute myocardial infarction is the most important of all baseline factors for prediction of 1 year survival. Mathematic models based on left ventricular function measured as ejection fraction are useful for risk stratification in this setting. Circulation 74, No. 4, 703-711, 1986. THE RISK for recurrent cardiac events in the year after an acute myocardial infarction has been the subject of many investigations.-''0 These studies have demonstrated that certain patient characteristics permit the definition of high-and low-risk subgroups for recurrent cardiac events. Typically, risk assessment was performed at the time of hospital discharge,3-10 although several groups have applied the concept of risk assessment during the first 24 hr of hospitalization. ' 2 Interventional therapies in the first hours of acute
myocardial infarction have been applied in hopes of decreasing infarct size and improving subsequent survival. [11] [12] [13] [14] [15] [16] Because the myocardial infarction process is progressive over time, 171 1 patients must be selected for interventional therapy at the time of hospitalization. The concept of risk stratification may also be applicable in this setting. If high-and low-risk subgroups for subsequent mortality can be defined at the time of hospitalization, the relative risk for subsequent mortality in a given patient can be balanced against the risks and potential benefits of interventional therapy.
In this report, we evaluate the relationship between 1 year survival outcome and patient historical, clinical, and angiographic characteristics identified a mean of 4.6 ± 2. 1 hr after the onset of acute myocardial infarction in 245 patients. From this analysis, models defining probability of 1 year survival are developed. Application of these models in our population demonstrates their usefulness as prognostic devices for risk stratification in the first hours of acute myocardial infarction.
Methods
The prognostic models developed in this study are based on data acquired in the Western Washington Randomized Intracoronary Streptokinase Trial, the organization and results of which have been reported in detail previously.
Pertinent to this report, all eligible patients were 75 years of age or younger. and they had symptoms and typical electrocardiographic findings of acute myocardial infarction. They were without other life-limitĩ ng illness and had not required treatment for congestive heart failure before the entry event. All patients consented to enter this study using forms approved by our institutional Human Subjects Review Committee. Baseline clinical and electrocardiographic characteristics were recorded. then the patient underwent 30 degree right anterior oblique left ventricular angiography followed by coronary angiography. If coronary artery occlusion or subtotal occlusion with thrombosis was identified, patients were randomly allocated to routine coronarv care or intracoronary infusion of streptokinase. Patients without angiographic characteristics of coronary thrombosis were not enrolled in this trial. Two hundred fifty patients were enrolled; 1 16 were assigned to the control group and 134 to the streptokinase group. Mortality was determined in all patients at 30 days., 6 months, and 1 year.
Factors related to 1 Coronary angiograms were analyzed for the following information: ( 1) location of the infarct-related occlusion in the coronary bed, (2) extent of collateral blood flow to the infarct bed, (3) percent diameter stenosis of the infarct-related vessel on initial injection of contrast agent, and (4) in patients receiving streptokinase, the response to thrombolytic therapy. Complete reperfusion was defined as normal or nearly normal flow in the treated vessel distal to the initial occlusion, partial reperfusion was defined as incomplete filling and/or delayed washout of the distal vessel, and no reperfusion was defined as the absence of contrast in the distal vessel after treatment. t had not been treated for congestive heart failure before onset of the entry event. These patients did not have known life-limiting illnesses other than the acute myocardial infarction and had no contraindication to thrombolytic therapy. All patients had ST segment elevation on their entry ECGs. We think that these characteristics define a population of patients that is ideal for consideration for interventional therapy in the first hours of acute myocardial infarction. Our analysis is consistent with the findings of others who have studied the relationship between factors present in the first day of acute myocardial infarction and subsequent 1 year mortality. Patient age,' 2. 30 history of prior acute myocardial infarction,] '1 3 indirect manifestations of larger infarct size such as hypotension and pulmonary edema,' ' and anterior location of infarction by ECG3' 33 can all be defined in the first hours of the event and have been previously found to be associated with higher subsequent mortality. We have found the same results in this study. Most importantly though, we have found that a direct measurement of left ventricular function, the LVEF obtained within hours of onset of the acute myocardial infarction, is the most powerful predictor of subsequent 1 Thirty-four percent of patients with inferior acute myocardial infarction receiving standard treatment had initial LVEFs between 39% and 50%; 35% of the anterior acute myocardial infarction group receiving standard treatment had LVEFs in this range.
Before further implications of the models developed here are discussed, limitations of this study must be acknowledged. This analysis represents a post hoc approach without antecedent hypothesis. As such, the results of the analysis must be taken with caution. Further validation will require prospective application of the model in another group of patients. The patient population on which the prognostic model is based is relatively small. Only patients who were candidates for interventional therapy and who met strict entry criteria were included in this study. Thus, as was noted above, the model should apply best to patients who are similar to those in the Western Washington Trial. Despite these limitations, the strong predictive value of data obtained very early in the course of infarction is potentially important for the future management of acute myocardial infarction. Although there has been intense interest in interventional therapy in the last 4 to 5 years, invasively determined data obtained in patients receiving standard (not interventional) therapy is quite uncommon. This is the largest series of patients receiving standard therapy for acute myocardial infarction in whom baseline quantitative analysis of left ventricular function has been performed. This series has been large enough to permit evaluation of baseline factors that influence 1 year survival in this type of patient so that a model potentially useful for determining prognosis could be developed.
Optimal implementation of our suggested approach to risk stratification will require noninvasive assessment of left ventricular function when patients first present to the hospital. Radionuclide blood pool imaging is one noninvasive diagnostic method for measurement of LVEF. Correlation between radionuclide and contrast angiographic LVEFs is not perfect, however; in general, radionuclide LVEFs are slightly lower than contrast angiographic LVEFs.4O 41 Second, mathematic models developed here identify high-and low-risk patient groups based on factors defined in the first hours of acute myocardial infarction and illustrate the impact of interventional therapies given 3.5 to 6.0 hr after onset of the event.
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